Overview

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of bavituximab when administered via a vein, and to examine how bavituximab behaves in the body - how quickly it is taken up by the body and how long it stays there. The effect of bavituximab on tumor responses will also be examined.
Phase:
Phase 1
Details
Lead Sponsor:
Peregrine Pharmaceuticals
Treatments:
Antibodies, Monoclonal
Bavituximab